Ｐａｇｅ 120259 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 通常モードに戻る ┃ ＩＮＤＥＸ ┃ ≪前へ │ 次へ≫ ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ▼EMEA Recommendz a N fuesitiouri 08/7/4(金) 2:41 ─────────────────────────────────────── ■題名 ： EMEA Recommendz a N ■名前 ： fuesitiouri <jateexesced@atlaskit.com> ■日付 ： 08/7/4(金) 2:41 ■Ｗｅｂ ： http://google.com/adybhv -------------------------------------------------------------------------
| LONDON, June 24, 2008-The European Medicines power (EMEA) has recommended updatikng the result intelligence for epoetin-containing medicines with a new indication for their use in cancer patients stating that blood transfusion should be the prederred method of correcting anaemia in patiets hardship cancer. Epoetin-containing medicines are indicated in patients with persistent achat viagra non-starter and for the treatment of anaemia in symptomatic patients with non-myeloid sarcomas receiving chemotherapy. The power痴 council flr sanative Products for Possibly manlike Use (CHMP) had noticeed new facts from studies that showed an increased endanger of sarcoma acheter viagra ascension, venous thromboembolism and sohrter all- inclusive survival in cancer patients who admitd epoetins compared to patients who did not admit them. Followingy this periodical, the CHMP concluded, at its June 2008 convocation, that the improvees of epoetins persist acheter cialis surpass their hazards in the approved indications.. be that as it may, in cancer patients with a reasonably covet flair-expectancy, the improve of using epoetins does not surpass the endanger acheter viagra generique sarcoma mvoement forward and shorter all-inclusive survival and for that resaon the council concluded that in these patients anaemia should be corrected with blood transfgusions. |